Neogen Corporation (NEOG) Social Stream
NEOGEN CORP (NEOG) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NEOGEN CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-12 | 2 | $25 | $25 | $25 | $19.45 | 28.53% |
| 2022-08-01 | 2 | $26 | $26 | $26 | $19.45 | 33.68% |
| 2022-08-30 | 2 | $20 | $20 | $20 | $19.45 | 2.83% |
| 2022-10-10 | 2 | $14 | $14 | $14 | $19.45 | -28.02% |
| 2022-12-14 | 2 | $17 | $17 | $17 | $19.45 | -12.6% |
| 2023-01-20 | 2 | $20 | $20 | $20 | $19.45 | 2.83% |
| 2023-04-11 | 2 | $19 | $19 | $19 | $19.45 | -2.31% |
| 2023-06-16 | 3 | $22 | $19 | $20.5 | $19.45 | 5.4% |
| 2023-08-07 | 3 | $24 | $22 | $23 | $19.45 | 18.25% |
| 2023-08-14 | 3 | $28 | $24 | $26 | $19.45 | 33.68% |
| 2023-10-15 | 3 | $28 | $17 | $22.5 | $19.45 | 15.68% |
| 2023-11-24 | 3 | $28 | $17.5 | $22.75 | $19.45 | 16.97% |
| NA | 1 | $NA | $NA | $NA | $19.45 | NA% |
The Trend in the Analyst Price Target
NEOG's average price target has moved down $54.75 over the prior 42 months.
NEOG reports an average of 17.41% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-10 | 2 | 19 | 19.0 | 19.00 | 17.30 | 9.83% |
| 2023-04-11 | 2 | 19 | 19.0 | 19.00 | 17.54 | 8.32% |
| 2023-06-16 | 3 | 22 | 19.0 | 20.50 | 20.77 | -1.3% |
| 2023-08-14 | 3 | 28 | 24.0 | 26.00 | 23.61 | 10.12% |
| 2023-11-24 | 3 | 28 | 17.5 | 22.75 | 16.86 | 34.93% |
NEOG Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 153 days, NEOG's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NEOG as an investment opportunity.
- In terms of how NEOGEN CORP fares relative to all US stocks, note that its number of analysts covering the stock is greater than 53.88% of that group.
- In the context of Pharmaceutical Products stocks, NEOGEN CORP's variance in analysts' estimates is lower than 17.72% of them.
- NEOGEN CORP's upside potential (average analyst target price relative to current price) is greater than 200.88% of Pharmaceutical Products stocks.
- NEOGEN CORP's average analyst price target is greater than 336.2% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, EVO, MOR, and RCUS are the three stocks most similar to NEOGEN CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is NEOG a Buy, Hold or Sell? See the POWR Ratings now!